Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4c47f9c90cd40ecd2a1051904c1bf4c |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352 |
filingDate |
1999-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab39b217ea93385df9e5381283e7d4f1 |
publicationDate |
2001-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CZ-20004622-A3 |
titleOfInvention |
A preparation for the prevention and / or treatment of osteoporosis and changes caused by menopause syndrome |
abstract |
A formulation is described which may be in the form of a supplementnnutritional or actual drug containing as characteristicnthe active ingredient propionyl L-carnitine and isoflavone genisteinnfor the prevention and / or therapeutic treatment of osteoporosis and syndromenmenopause. |
priorityDate |
1999-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |